This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erkut, Z. A. Articles by Swaab, D. F. Search for Related Content PubMed PubMed Citation Articles by Erkut, Z. A. Articles by Swaab, D. F.

Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons¹

Netherlands Institute for Brain Research, Graduate School Neurosciences, Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: Dr. Zeynel A. Erkut, Netherlands Institute for Brain Research, Meibergdreef 33, 1105 AZ Amsterdam, The Netherlands. E-mail: e.zeynel{at}nih.knaw.nl

Glucocorticoids are widely used in clinical practice in a variety of immune-mediated and neoplastic diseases, mostly for their immunosuppressive, leukopenic, antiedematous, or malignancy-suppressive actions. However, their usage is limited because of serious and sometimes life-threatening side-effects.

Endogenous glucocorticoids are secreted by the adrenal cortex under the control of the hypothalamus and the pituitary gland. This hypothalamo-pituitary-adrenal axis, in turn, is under the negative feedback control of glucocorticoids. Although the suppression of adrenocortical and pituitary gland functions by glucocorticoids has been shown in humans, a feedback effect at the level of the hypothalamus, as shown in rat, has not been reported to date. The present study shows for the first time that glucocorticoids suppress both CRH and vasopressin (AVP) in the human hypothalamus. We studied immunocytochemically the postmortem hypothalami of nine corticosteroid-exposed subjects and eight controls. The number of CRH-expressing cells in the hypothalamic paraventricular nucleus of glucocorticoid-exposed patients was only 3.3% of that in the controls, and the total immunoreactivities for AVP were 31% and 33% of that in the controls in the supraoptic nucleus and the paraventricular nucleus, respectively, whereas the immunoreactivity for oxytocin did not differ between the two groups.

Suppression of hypothalamic CRH and AVP neurons by glucocorticoids may have important consequences for neuroendocrinological mechanisms such as the disturbance of water balance during the treatment as well as the immunological processes in the brain and the pathogenesis of the withdrawal syndrome after discontinuation of corticosteroid treatment. In addition, as both AVP and CRH neurons also project to other brain structures and influence memory, mood, and behavior, their suppression by glucocorticoids may be responsible for at least part of the central nervous system side-effects of glucocorticoids.

This article has been cited by other articles:

				T. R. Pak, W. C. J. Chung, L. R. Hinds, and R. J. Handa Arginine vasopressin regulation in pre- and postpubertal male rats by the androgen metabolite 3{beta}-diol Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1409 - E1413. [Abstract] [Full Text] [PDF]

				A. Iranmanesh and J. D Veldhuis Hypocortisolemic clamp unmasks jointly feedforward- and feedback-dependent control of overnight ACTH secretion Eur. J. Endocrinol., November 1, 2008; 159(5): 561 - 568. [Abstract] [Full Text] [PDF]

				T. R. Pak, W. C. J. Chung, L. R. Hinds, and R. J. Handa Estrogen Receptor-{beta} Mediates Dihydrotestosterone-Induced Stimulation of the Arginine Vasopressin Promoter in Neuronal Cells Endocrinology, July 1, 2007; 148(7): 3371 - 3382. [Abstract] [Full Text] [PDF]

				A. Alkemade, U. A. Unmehopa, W. M. Wiersinga, D. F. Swaab, and E. Fliers Glucocorticoids Decrease Thyrotropin-Releasing Hormone Messenger Ribonucleic Acid Expression in the Paraventricular Nucleus of the Human Hypothalamus J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 323 - 327. [Abstract] [Full Text] [PDF]

				C. L. Raison and A. H. Miller When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders Am J Psychiatry, September 1, 2003; 160(9): 1554 - 1565. [Abstract] [Full Text] [PDF]

				Z.'e. Hochberg, K. Pacak, and G. P. Chrousos Endocrine Withdrawal Syndromes Endocr. Rev., August 1, 2003; 24(4): 523 - 538. [Abstract] [Full Text] [PDF]

				M. Fodor, F. W. van Leeuwen, and D. F. Swaab Differences in Postmortem Stability of Sex Steroid Receptor Immunoreactivity in Rat Brain J. Histochem. Cytochem., May 1, 2002; 50(5): 641 - 650. [Abstract] [Full Text] [PDF]

				J. Preil, M. B. Muller, A. Gesing, J. M. H. M. Reul, I. Sillaber, M. M. van Gaalen, J. Landgrebe, F. Holsboer, M. Stenzel-Poore, and W. Wurst Regulation of the Hypothalamic-Pituitary-Adrenocortical System in Mice Deficient for CRH Receptors 1 and 2 Endocrinology, November 1, 2001; 142(11): 4946 - 4955. [Abstract] [Full Text] [PDF]

				P. J. Lucassen, M. B. Muller, F. Holsboer, J. Bauer, A. Holtrop, J. Wouda, W. J. G. Hoogendijk, E. R. De Kloet, and D. F. Swaab Hippocampal Apoptosis in Major Depression Is a Minor Event and Absent from Subareas at Risk for Glucocorticoid Overexposure Am. J. Pathol., February 1, 2001; 158(2): 453 - 468. [Abstract] [Full Text] [PDF]

				A. Plagemann, T. Harder, A. Rake, K. Melchior, W. Rohde, and G. Dörner Hypothalamic Nuclei Are Malformed in Weanling Offspring of Low Protein Malnourished Rat Dams J. Nutr., October 1, 2000; 130(10): 2582 - 2589. [Abstract] [Full Text]

				M. M. Sanchez, L. J. Young, P. M. Plotsky, and T. R. Insel Distribution of Corticosteroid Receptors in the Rhesus Brain: Relative Absence of Glucocorticoid Receptors in the Hippocampal Formation J. Neurosci., June 15, 2000; 20(12): 4657 - 4668. [Abstract] [Full Text] [PDF]